Evidence map›Paper›PMID 10577911›Full record

ArticleAmerican journal of human genetics1999

Mutation rates in humans. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B.

F Giannelli, T Anagnostopoulos, P M Green

Abstract read
In one paragraph

Article in American journal of human genetics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A genome-wide view of Caenorhabditis elegans base-substitution mutation processes.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  8. A genome-wide view of the spectrum of spontaneous mutations in yeast.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Uncertainty principle of genetic information in a living cell.Theoretical biology & medical modelling · 2005
    Article
  14. Article
  15. Article
  16. A Line 1 insertion in the Factor IX gene segregates with mild hemophilia B in dogs.Mammalian genome : official journal of the International Mammalian Genome Society · 2003
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

F GiannelliDivision of Medical and Molecular Genetics, Guy's, King's, and St. Thomas' School of Medicine, Guy's Campus, London SE1 9RT, United Kingdom. francesco.giannelli@kcl.ac.uk.
T Anagnostopoulos
P M Green

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We estimated the rates per base per generation of specific types of mutations, using our direct estimate of the overall mutation rate for hemophilia B and information on the mutations present in the United Kingdom's population as well as those reported year by year in the hemophilia B world database. These rates are as follows: transitions at CpG sites 9.7x10-8, other transitions 7.3x10-9, transversions at CpG sites 5.4x10-9, other transversions 6.9x10-9, and small deletions/insertions causing frameshifts 3.2x10-10. By taking into account the ratio of male to female mutation rates, the above figures were converted into rates appropriate for autosomal DNA-namely, 1.3x10-7, 9.9x10-9, 7.3x10-9, 9.4x10-9, 6.5x10-10, where the latter is the rate for all small deletion/insertion events. Mutation rates were also independently estimated from the sequence divergence observed in randomly chosen sequences from the human and chimpanzee X and Y chromosomes. These estimates were highly compatible with those obtained from hemophilia B and showed higher mutation rates in the male, but they showed no evidence for a significant excess of transitions at CpG sites in the spectrum of Y-sequence divergence relative to that of X-chromosome divergence. Our data suggest an overall mutation rate of 2.14x10-8 per base per generation, or 128 mutations per human zygote. Since the effective target for hemophilia B mutations is only 1.05% of the factor IX gene, the rate of detrimental mutations, per human zygote, suggested by the hemophilia data is approximately 1.3.

Indexed as

AnimalsCpG IslandsDatabases, FactualDNA Mutational AnalysisEvolution, MolecularFactor IXFemaleGene FrequencyGenome, HumanHemophilia BHumansMaleMutationPan troglodytesPhenotypeSex CharacteristicsFactor IX

Identifiers

PMID10577911
PMCPMC1288368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.